Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthralgia
Findings from University Hospital broaden understanding of arthralgia
August 21st, 2008
" Arthralgia is an adverse class effect of aromatase inhibitors (AIs). To date, its exact mechanism remains unclear," scientists writing in the Journal of Clinical Oncology report. "The purpose of this study was to investigate the changes in clinical rheumatologic features and magnetic resonance imaging (MRI) of hands and wrists in AI and tamoxifen users. Patients and Methods This is a prospective single-center study including 17 consecutive postmenopausal patients with early breast cancer receiving either tamoxifen (n = 5) or an AI (n = 12). At baseline and after 6 months, patients filled in a rheumatologic history questionnaire and a rheumatologic examination...
Source: Women's Health Weekly (2008-08-21)
|
